Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature].
Viens P, Bertucci F, Gravis G, Camerlo J, Cowen D, Delpero JR, Conte M, Jacquemier J, Faucher C, Blaise D, Bardou VJ, Chabannon C, Blanc AP, Jaubert D, Maraninchi D. Viens P, et al. Among authors: camerlo j. Bull Cancer. 1997 Sep;84(9):869-76. Bull Cancer. 1997. PMID: 9435808 Free article. Review. French.
Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery.
Faucher C, Le Corroller AG, Chabannon C, Viens P, Stoppa AM, Bouabdallah R, Camerlo J, Vey N, Gravis G, Gastaut JA, Novakovitch G, Mannoni P, Bardou VJ, Moatti JP, Maraninchi D, Blaise D. Faucher C, et al. Among authors: camerlo j. J Hematother. 1996 Dec;5(6):663-70. doi: 10.1089/scd.1.1996.5.663. J Hematother. 1996. PMID: 9117255
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution.
Oddou S, Vey N, Viens P, Bardou VJ, Faucher C, Stoppa AM, Chabannon C, Camerlo J, Bouabdallah R, Gastaut JA, Maraninchi D, Blaise D. Oddou S, et al. Among authors: camerlo j. Leuk Lymphoma. 1998 Sep;31(1-2):187-94. doi: 10.3109/10428199809057598. Leuk Lymphoma. 1998. PMID: 9720728 Clinical Trial.
High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.
Chabannon C, Cornetta K, Lotz JP, Rosenfeld C, Shlomchik M, Yanovitch S, Marolleau JP, Sledge G, Novakovitch G, Srour EF, Burtness B, Camerlo J, Gravis G, Lee-Fischer J, Faucher C, Chabbert I, Krause D, Maraninchi D, Mills B, Kunkel L, Oldham F, Blaise D, Viens P. Chabannon C, et al. Among authors: camerlo j. Br J Cancer. 1998 Oct;78(7):913-21. doi: 10.1038/bjc.1998.601. Br J Cancer. 1998. PMID: 9764583 Free PMC article. Clinical Trial.
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy.
Viens P, Jacquemier J, Bardou VJ, Bertucci F, Penault-Llorca F, Puig B, Gravis G, Oziel-Taïeb S, Resbeut M, Houvenaeghel G, Camerlo J, Birbaum D, Hassoun J, Maraninchi D. Viens P, et al. Among authors: camerlo j. Breast Cancer Res Treat. 1999 Apr;54(3):205-12. doi: 10.1023/a:1006112927565. Breast Cancer Res Treat. 1999. PMID: 10445419
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation.
Braud AC, Mathoulin Portier MP, Bardou VJ, Bertucci F, Gravis G, Camerlo J, Begue M, Houvenaeghel G, Maraninchi D, Jacquemier J, Viens P. Braud AC, et al. Among authors: camerlo j. Bone Marrow Transplant. 2002 May;29(9):753-7. doi: 10.1038/sj.bmt.1703540. Bone Marrow Transplant. 2002. PMID: 12040472
52 results